1. Home
  2. ANY vs MEIP Comparison

ANY vs MEIP Comparison

Compare ANY & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANY
  • MEIP
  • Stock Information
  • Founded
  • ANY N/A
  • MEIP 2000
  • Country
  • ANY United States
  • MEIP United States
  • Employees
  • ANY 4
  • MEIP N/A
  • Industry
  • ANY Finance: Consumer Services
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANY Finance
  • MEIP Health Care
  • Exchange
  • ANY Nasdaq
  • MEIP Nasdaq
  • Market Cap
  • ANY 22.9M
  • MEIP 13.3M
  • IPO Year
  • ANY N/A
  • MEIP 2003
  • Fundamental
  • Price
  • ANY $0.79
  • MEIP $2.15
  • Analyst Decision
  • ANY Strong Buy
  • MEIP Hold
  • Analyst Count
  • ANY 1
  • MEIP 1
  • Target Price
  • ANY $3.00
  • MEIP N/A
  • AVG Volume (30 Days)
  • ANY 580.1K
  • MEIP 6.2K
  • Earning Date
  • ANY 05-14-2025
  • MEIP 05-13-2025
  • Dividend Yield
  • ANY N/A
  • MEIP N/A
  • EPS Growth
  • ANY N/A
  • MEIP N/A
  • EPS
  • ANY N/A
  • MEIP N/A
  • Revenue
  • ANY $12,479,000.00
  • MEIP N/A
  • Revenue This Year
  • ANY N/A
  • MEIP N/A
  • Revenue Next Year
  • ANY N/A
  • MEIP N/A
  • P/E Ratio
  • ANY N/A
  • MEIP N/A
  • Revenue Growth
  • ANY N/A
  • MEIP 33.76
  • 52 Week Low
  • ANY $0.36
  • MEIP $1.46
  • 52 Week High
  • ANY $1.90
  • MEIP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • ANY 57.42
  • MEIP 51.32
  • Support Level
  • ANY $0.71
  • MEIP $2.05
  • Resistance Level
  • ANY $0.90
  • MEIP $2.24
  • Average True Range (ATR)
  • ANY 0.09
  • MEIP 0.12
  • MACD
  • ANY -0.01
  • MEIP 0.01
  • Stochastic Oscillator
  • ANY 31.42
  • MEIP 56.52

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: